#Pharma Merck Serono sets up #cancer platform | Pharmafile http://t.co/DtvURZU8TA
July 04, 2013
/http%3A%2F%2Fwww.pharmafile.com%2Fsites%2Fdefault%2Ffiles%2Fu5%2FFocusTwitBUT.gif)
Merck Serono sets up cancer platform
Merck Serono is attempting to speed up R&D on products which stimulate the immune system to fight cancer by establishing what it calls an immuno-oncology platform. It will consist of a dedicated, in-house team of researchers and clinicians in a trio of clusters who will join forces with academics, plus research and other pharma organisations to push candidate molecules from the bench to proof of confidence.